胱抑素C作为万古霉素给药生物标志物是否足够好：药代动力学视角 - Suppr

Suppr

超能文献

Is Cystatin C Good Enough as a Biomarker for Vancomycin Dosing: A Pharmacokinetic Perspective.

作者信息

Yu Guo, Li Guo-Fu

机构信息

Institution of Drug Clinical Trial, Subei People's Hospital, #98 West Nantong Rd, Yangzhou, Jiangsu, 225001, China.

College of Pharmacy, Dalian Medical University, Dalian, Liaoning, China.

出版信息

Eur J Drug Metab Pharmacokinet. 2020 Feb;45(1):151-156. doi: 10.1007/s13318-019-00587-3.

DOI:10.1007/s13318-019-00587-3

PMID:31691904

Abstract

摘要

相似文献

Is Cystatin C Good Enough as a Biomarker for Vancomycin Dosing: A Pharmacokinetic Perspective.

Eur J Drug Metab Pharmacokinet. 2020 Feb;45(1):151-156. doi: 10.1007/s13318-019-00587-3.

Cystatin C-Guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project.

Am J Kidney Dis. 2017 May;69(5):658-666. doi: 10.1053/j.ajkd.2016.11.016. Epub 2017 Jan 25.

A population pharmacokinetic model of vancomycin for dose individualization based on serum cystatin C as a marker of renal function.

J Pharm Pharmacol. 2019 Jun;71(6):945-955. doi: 10.1111/jphp.13071. Epub 2019 Mar 14.

Comparison of equations with estimate renal function to predict serum vancomycin concentration in patients with spinal cord injury--does the use of cystatin C improve accuracy?

Ther Drug Monit. 2014 Oct;36(5):632-9. doi: 10.1097/FTD.0000000000000065.

Serum cystatin C for the prediction of glomerular filtration rate with regard to the dose adjustment of amikacin, gentamicin, tobramycin, and vancomycin.

Ther Drug Monit. 2006 Jun;28(3):326-31. doi: 10.1097/01.ftd.0000211805.89440.3d.

High-dose aprotinin with gentamicin-vancomycin antibiotic prophylaxis increases blood concentrations of creatinine and cystatin C in patients undergoing coronary artery bypass grafting.

Br J Anaesth. 1999 Apr;82(4):531-6. doi: 10.1093/bja/82.4.531.

Estimated GFR and cystatin C for drug dosing: moving beyond proof of concept to clinical translation?

Am J Kidney Dis. 2015 Apr;65(4):534-6. doi: 10.1053/j.ajkd.2014.11.006. Epub 2014 Dec 24.

Estimation of the initial dose setting of vancomycin therapy with use of cystatin C as a new marker of renal function.

Ther Drug Monit. 2007 Apr;29(2):261-4. doi: 10.1097/FTD.0b013e31803bcfd2.

24-Hour Pharmacokinetic Relationships for Vancomycin and Novel Urinary Biomarkers of Acute Kidney Injury.

Antimicrob Agents Chemother. 2017 Oct 24;61(11). doi: 10.1128/AAC.00416-17. Print 2017 Nov.

Clearance of vancomycin during continuous infusion in Intensive Care Unit patients: correlation with measured and estimated creatinine clearance and serum cystatin C.

Int J Antimicrob Agents. 2010 Dec;36(6):545-8. doi: 10.1016/j.ijantimicag.2010.07.015. Epub 2010 Sep 21.

引用本文的文献

Use of Clearance Concepts to Simulate Impact of Interleukin-6 on Drug Elimination Governed by Cytochromes P450 3A4 and Glomerular Filtration Rate.

Eur J Drug Metab Pharmacokinet. 2023 Nov;48(6):619-621. doi: 10.1007/s13318-023-00859-z. Epub 2023 Oct 4.

Diagnostic Value of Multiple Serum Biomarkers for Vancomycin-Induced Kidney Injury.

J Clin Med. 2021 Oct 27;10(21):5005. doi: 10.3390/jcm10215005.

本文引用的文献

Comparison of the Predictive Performance Between Cystatin C and Serum Creatinine by Vancomycin via a Population Pharmacokinetic Models: A Prospective Study in a Chinese Population.

Eur J Drug Metab Pharmacokinet. 2020 Feb;45(1):135-149. doi: 10.1007/s13318-019-00578-4.

Development and comparison of population pharmacokinetic models of vancomycin in neurosurgical patients based on two different renal function markers.

J Clin Pharm Ther. 2020 Feb;45(1):88-96. doi: 10.1111/jcpt.13029. Epub 2019 Aug 28.

A population pharmacokinetic model of vancomycin for dose individualization based on serum cystatin C as a marker of renal function.

J Pharm Pharmacol. 2019 Jun;71(6):945-955. doi: 10.1111/jphp.13071. Epub 2019 Mar 14.

Impact of Ethnicity-Specific Hepatic Microsomal Scaling Factor, Liver Weight, and Cytochrome P450 (CYP) 1A2 Content on Physiologically Based Prediction of CYP1A2-Mediated Pharmacokinetics in Young and Elderly Chinese Adults.

Clin Pharmacokinet. 2019 Jul;58(7):927-941. doi: 10.1007/s40262-019-00737-5.

Interethnic scaling of fraction unbound of a drug in plasma and volume of distribution: an analysis of extrapolation from Caucasians to Chinese.

Eur J Clin Pharmacol. 2019 Apr;75(4):543-551. doi: 10.1007/s00228-018-02610-z. Epub 2018 Dec 19.

Quantitative Estimation of Plasma Free Drug Fraction in Patients With Varying Degrees of Hepatic Impairment: A Methodological Evaluation.

J Pharm Sci. 2018 Jul;107(7):1948-1956. doi: 10.1016/j.xphs.2018.02.021. Epub 2018 Mar 6.

Modeling Drug Disposition and Drug-Drug Interactions Through Hypothesis-Driven Physiologically Based Pharmacokinetics: a Reversal Translation Perspective.

Eur J Drug Metab Pharmacokinet. 2018 Jun;43(3):369-371. doi: 10.1007/s13318-017-0452-8.

Cystatin C-Guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project.

Am J Kidney Dis. 2017 May;69(5):658-666. doi: 10.1053/j.ajkd.2016.11.016. Epub 2017 Jan 25.

Creatinine Clearance Is Not Equal to Glomerular Filtration Rate and Cockcroft-Gault Equation Is Not Equal to CKD-EPI Collaboration Equation.

Am J Med. 2016 Dec;129(12):1259-1263. doi: 10.1016/j.amjmed.2016.08.019. Epub 2016 Sep 6.

Usefulness of serum cystatin C to determine the dose of vancomycin in neonate.

Korean J Pediatr. 2015 Nov;58(11):421-6. doi: 10.3345/kjp.2015.58.11.421. Epub 2015 Nov 22.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验